including fentanyl and fentanyl analogues, to 
include the following: 
‘‘(i) The scale of legal domestic pro-
duction and any available information on 
the number of manufacturers and pro-
ducers of such opioids in such countries. 
‘‘(ii) Information on any law enforce-
ment assessments of the scale of illegal 
production, including a description of the 
capacity of illegal laboratories to produce 
such opioids. 
‘‘(iii) The types of inputs used and a 
description of the primary methods of syn-
thesis employed by illegal producers of 
such opioids. 
‘‘(iv) An assessment of the policies of 
such countries to regulate licit manufac-
ture and interdict illicit manufacture, di-
version, distribution, and shipment of such 
opioids and an assessment of the effective-
ness of the policies’ implementation. 
‘‘(B) NEW PSYCHOACTIVE SUBSTANCES.— 
Information on the policies of responding to 
new psychoactive substances (as such term is
defined in section 7 of the FENTANYL Results 
Act), to include the following: 
‘‘(i) Which governments have articu-
lated policies on scheduling of such sub-
stances. 
‘‘(ii) Any data on impacts of such 
policies and other responses to such sub-
stances. 
‘‘(iii) An assessment of what policies 
the United States may want to consider 
articulating.’’. 
(b) DEFINITION
OF MAJOR ILLICIT DRUG PRO-
DUCING COUNTRY.—Section 481(e) of the Foreign Assist-
ance Act of 1961 (22 U.S.C. 2291(e)) is amended— 
(1) in paragraph (2)— 
(A) by striking ‘‘means a country in 
which—’’ and inserting ‘‘means— 
‘‘(A) a country in which—’’; 
(B) by striking ‘‘(A) 1,000’’ and inserting 
the following: 
‘‘(i) 1,000’’; 
(C) by striking ‘‘(B) 1,000’’ and inserting 
the following: 
‘‘(ii) 1,000’’;
(D) by striking ‘‘(C) 5,000’’ and inserting 
the following: 
‘‘(iii) 5,000’’; 
(E) in subparagraph (A)(iii), as redesig-
nated by this subsection, by adding ‘‘or’’ at the 
end; and 
(F) by adding at the end the following: 
‘‘(B) a country which is a significant direct 
source of illicit narcotic or psychotropic drugs 
or other controlled substances significantly af-
fecting the United States.’’; and 
(2) in paragraph (5) to read as follows: 
‘‘(5) the term ‘major drug-transit country’ 
means a country through which illicit narcotic or 
psychotropic drugs or other controlled substances 
significantly affecting the United States are trans-
ported.’’. 
SEC. 6. SENSE OF CONGRESS. 
It is the sense of Congress that— 
(1) the President should direct the United 
States Representative to the United Nations to use 
the voice and vote of the United States at the 
United Nations to advocate for more transparent as-
sessments of countries by the International Nar-
cotics Control Board; and
(2) bilateral, plurilateral, and multilateral inter-
national cooperation is essential to combating the 
trafficking of covered synthetic drugs. 
SEC. 7. DEFINITION. 
In this Act: 
(1) The term ‘‘covered synthetic drug’’ means— 
(A) a synthetic controlled substance (as de-
fined in section 102(6) of the Controlled Sub-
stances Act (21 U.S.C. 802(6))), including 
fentanyl or a fentanyl analogue; or 
(B) a new psychoactive substance. 
(2) The term ‘‘new psychoactive substance’’ 
means a substance of abuse, or any preparation 
thereof, that— 
(A) is not— 
(i) included in any schedule as a con-
trolled substance under the Controlled 
Substances Act (21 U.S.C. 801 et seq.); or 
(ii) controlled by the Single Conven-
tion on Narcotic Drugs signed at New 
York, New York, on March 30, 1961, or 
the Convention on Psychotropic Substances 
signed at Vienna, Austria, on February 21, 
1971;
(B) is new or has reemerged on the illicit 
market; and 
(C) poses a threat to the public health and 
safety. 
Passed the House of Representatives November 18, 
2020. 
Attest: 
Clerk.
116TH CONGRESS 
2D SESSION 
H. R. 7990 
AN ACT 
To prioritize efforts of the Department of State to 
combat international trafficking in covered syn-
thetic drugs and new psychoactive substances, 
and for other purposes.